메뉴 건너뛰기




Volumn 14, Issue 10, 2013, Pages 1319-1332

Current treatment of community-acquired pneumonia

Author keywords

Community acquired pneumonia; Guidelines; Steroids; Treatment

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFTAROLINE; CEFTAZIDIME; CEFTRIAXONE; CETHROMYCIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CL 05 001; CL 06 001; CLARITHROMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DORIPENEM; DOXYCYCLINE; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MEROPENEM; MOXIFLOXACIN; OSELTAMIVIR; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SOLITHROMYCIN; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; ZANAMIVIR;

EID: 84878893147     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2013.798647     Document Type: Review
Times cited : (9)

References (92)
  • 1
    • 63149192143 scopus 로고    scopus 로고
    • Global and local epidemiology of community-acquired pneumonia: The experience of the CAPNETZ network
    • Welte T, Kohnlein T. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ network. Semin Respir Crit Care Med 2009;30:127-35
    • (2009) Semin Respir Crit Care Med , vol.30 , pp. 127-135
    • Welte, T.1    Kohnlein, T.2
  • 2
    • 82455172268 scopus 로고    scopus 로고
    • Community acquired pneumonia: An unfinished battle
    • Nair GB, Niederman MS. Community acquired pneumonia: an unfinished battle. Med Clin North Am 2011;95:1143-61
    • (2011) Med Clin North Am , vol.95 , pp. 1143-1161
    • Nair, G.B.1    Niederman, M.S.2
  • 3
    • 33847155159 scopus 로고    scopus 로고
    • Infectious diseases society of america/american thoracic society consensus guidelines on the management of community-acquired pneumonia in adults
    • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-72
    • (2007) Clin Infect Dis , vol.44 , Issue.SUPPL. 2
    • Mandell, L.A.1    Wunderink, R.G.2    Anzueto, A.3
  • 4
    • 82555194473 scopus 로고    scopus 로고
    • New guidelines for the management of adult lower respiratory tract infections
    • Woodhead M. New guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2011;38(6):1250-1
    • (2011) Eur Respir J , vol.38 , Issue.6 , pp. 1250-1251
    • Woodhead, M.1
  • 5
    • 84874760594 scopus 로고    scopus 로고
    • En nombre del Grupo de la Gua Multidisciplinar para el Manejo de la Neumona Adquirida en la Comunidad.
    • e1-223.e19. Spanish
    • Torres A, Barberan J, Falguera M, en nombre del Grupo de la Gua Multidisciplinar para el Manejo de la Neumona Adquirida en la Comunidad. Multidisciplinary guidelines for the management of community-acquired pneumonia. Med Clin (Barc) 2013;140(5):223; e1-223.e19. Spanish
    • (2013) Med Clin (Barc) , vol.140 , Issue.5 , pp. 223
    • Torres, A.1    Barberan, J.2    Falguera, M.3
  • 6
    • 58849141687 scopus 로고    scopus 로고
    • Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
    • Dambrava PG, Torres A, Valles X, et al. Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome. Eur Respir J 2008;32(4):892-901
    • (2008) Eur Respir J , vol.32 , Issue.4 , pp. 892-901
    • Dambrava, P.G.1    Torres, A.2    Valles, X.3
  • 7
    • 28744442236 scopus 로고    scopus 로고
    • Community-acquired pneumonia intensive care units (capuci) study investigators antibiotic prescription for community-acquired pneumonia in the intensive care unit: Impact of adherence to infectious diseases society of america guidelines on survival
    • Bod M, Rodrguez A, Sole-Violan J, et al. Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious diseases Society of America guidelines on survival. Clin Infect Dis 2005;41(12):1709-16
    • (2005) Clin Infect Dis , vol.41 , Issue.12 , pp. 1709-1716
    • Bod, M.1    Rodrguez, A.2    Sole-Violan, J.3
  • 8
    • 70349252247 scopus 로고    scopus 로고
    • Guideline concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: Playing by the rules
    • McCabe C, Kirchner C, Zhang H, et al. Guideline concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Ann Intern Med 2009;169(16):1525-31
    • (2009) Ann Intern Med , vol.169 , Issue.16 , pp. 1525-1531
    • McCabe, C.1    Kirchner, C.2    Zhang, H.3
  • 9
    • 77649151752 scopus 로고    scopus 로고
    • Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit
    • Frei CR, Attridge RT, Mortensen EM, et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther 2010;32:293-9
    • (2010) Clin Ther , vol.32 , pp. 293-299
    • Frei, C.R.1    Attridge, R.T.2    Mortensen, E.M.3
  • 10
    • 1642286527 scopus 로고    scopus 로고
    • Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia
    • Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-44
    • (2004) Arch Intern Med , vol.164 , pp. 637-644
    • Houck, P.M.1    Bratzler, D.W.2    Nsa, W.3
  • 11
    • 33746334760 scopus 로고    scopus 로고
    • Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia
    • Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest 2006;130(1):11-15
    • (2006) Chest , vol.130 , Issue.1 , pp. 11-15
    • Waterer, G.W.1    Kessler, L.A.2    Wunderink, R.G.3
  • 12
    • 23744472099 scopus 로고    scopus 로고
    • Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: A prospective randomized study
    • van der Eerden MM, Vlaspolder F, de Graaff CS, et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomized study. Thorax. 2005; 60(8):672-8.
    • (2005) Thorax , vol.60 , Issue.8 , pp. 672-672
    • Van Der Eerden, M.M.1    Vlaspolder, F.2    De Graaff, C.S.3
  • 13
    • 84862499347 scopus 로고    scopus 로고
    • Community acquired pneumonia guidelines: A global perspective
    • Niederman M, Luna C. Community acquired pneumonia guidelines: a global perspective. Semin Respir Crit Care Med 2012;33:298-310
    • (2012) Semin Respir Crit Care Med , vol.33 , pp. 298-310
    • Niederman, M.1    Luna, C.2
  • 14
    • 34249304464 scopus 로고    scopus 로고
    • Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock
    • Rodrguez A, Mendia A, Sirvent JM, CAPUCI Study Group. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med 2007;35(6):1493-8
    • (2007) Crit Care Med , vol.35 , Issue.6 , pp. 1493-1498
    • Rodrguez, A.1    Mendia, A.2    Sirvent, J.M.3
  • 15
    • 63249091069 scopus 로고    scopus 로고
    • The science of selecting antimicrobials for community -acquired pneumonia (CAP)
    • File T. The science of selecting antimicrobials for community -acquired pneumonia (CAP). J Manag Care Pharm 2009;15(2 Suppl):S5-11
    • (2009) J Manag Care Pharm , vol.15 , Issue.2 SUPPL.
    • File, T.1
  • 16
    • 33745832293 scopus 로고    scopus 로고
    • Antibiotic dosage regimens in respiratory tract infections in the pharmacokinetic/pharmacodynamic era
    • 9
    • Soy D, Badia JR, Torres A. Antibiotic dosage regimens in respiratory tract infections in the pharmacokinetic/pharmacodynamic era. Curr Respir Med Rev 2006;2(1):89-97; 9
    • (2006) Curr Respir Med Rev , vol.2 , Issue.1 , pp. 89-97
    • Soy, D.1    Badia, J.R.2    Torres, A.3
  • 17
    • 45949106769 scopus 로고    scopus 로고
    • Pharmacodynamic optimization of b-lactams in the patient care setting
    • Nicolau DP. Pharmacodynamic optimization of b-lactams in the patient care setting. Crit Care 2008;12:S2
    • (2008) Crit Care , vol.12
    • Nicolau, D.P.1
  • 18
    • 0141676184 scopus 로고    scopus 로고
    • High-dose, short-course levofloxacin for community-acquired pneumonia: A new treatment paradigm
    • Dunbar LM, Wunderink RG, Habib MP, et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003;37(6):752-60
    • (2003) Clin Infect Dis , vol.37 , Issue.6 , pp. 752-760
    • Dunbar, L.M.1    Wunderink, R.G.2    Habib, M.P.3
  • 19
    • 33750849023 scopus 로고    scopus 로고
    • Levofloxacin 750-mg for 5 days for the treatment of hospitalized fine risk class III/IV community-acquired pneumonia patients
    • Shorr AF, Khashab MM, Xiang JX, et al. Levofloxacin 750-mg for 5 days for the treatment of hospitalized fine risk class III/IV community-acquired pneumonia patients. Respir Med 2006;100(12):2129-36
    • (2006) Respir Med , vol.100 , Issue.12 , pp. 2129-2136
    • Shorr, A.F.1    Khashab, M.M.2    Xiang, J.X.3
  • 20
    • 34548355192 scopus 로고    scopus 로고
    • Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data
    • Burgess DS, Hall RG II. Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data. Clin Ther 2007;29(7):1421-7
    • (2007) Clin Ther , vol.29 , Issue.7 , pp. 1421-1427
    • Burgess, D.S.1    Hall, R.G.I.I.2
  • 21
    • 0030802009 scopus 로고    scopus 로고
    • Intermittent bolus dosing of ceftazidime in critically ill patients
    • Young RJ, Lipman J, Gin T, et al. Intermittent bolus dosing of ceftazidime in critically ill patients. J Antimicrob Chemother 1997;40:269-73
    • (1997) J Antimicrob Chemother , vol.40 , pp. 269-273
    • Young, R.J.1    Lipman, J.2    Gin, T.3
  • 22
    • 0031772904 scopus 로고    scopus 로고
    • Continuous vs intermittent infusion of cefuroxime for the treatment of community-acquired pneumonia
    • Ambrose PG, Quindliani R, Nightingale CH, Nicolau DP. Continuous vs. intermittent infusion of cefuroxime for the treatment of community-acquired pneumonia. Infect Dis Clin Pract 1998;7:463-70
    • (1998) Infect Dis Clin Pract , vol.7 , pp. 463-470
    • Ambrose, P.G.1    Quindliani, R.2    Nightingale, C.H.3    Nicolau, D.P.4
  • 23
    • 80052672933 scopus 로고    scopus 로고
    • Antibiotics in critically ill patients: A systematic review of the pharmacokinetics of b-lactams
    • Review
    • Goncalves-Pereira J, Povoa P. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of b-lactams. Crit Care 2011;15(5):13; Review
    • (2011) Crit Care , vol.15 , Issue.5 , pp. 13
    • Goncalves-Pereira, J.1    Povoa, P.2
  • 24
    • 66449092115 scopus 로고    scopus 로고
    • A systematic review on clinical benefits of continuous administration of b-lactam antibiotics
    • Roberts JA, Webb S, Paterson D, et al. A systematic review on clinical benefits of continuous administration of b-lactam antibiotics. Crit Care Med 2009;37:2071-8
    • (2009) Crit Care Med , vol.37 , pp. 2071-2078
    • Roberts, J.A.1    Webb, S.2    Paterson, D.3
  • 25
    • 23944504296 scopus 로고    scopus 로고
    • Continuous versus intermittent intravenous administration of antibiotics: A meta-analysis of randomized controlled trials
    • Kasiakou SK, Sermaides GJ, Michalopoulos A, et al. Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomized controlled trials. Lancet Infect Dis 2005;5:581-9
    • (2005) Lancet Infect Dis , vol.5 , pp. 581-589
    • Kasiakou, S.K.1    Sermaides, G.J.2    Michalopoulos, A.3
  • 26
    • 84855410035 scopus 로고    scopus 로고
    • Initial management of pneumonia and sepsis: Factors associated with improved outcome
    • Menendez R, Torres A, Reyes S, et al. Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur Respir J 2012;39(1):156-62
    • (2012) Eur Respir J , vol.39 , Issue.1 , pp. 156-162
    • Menendez, R.1    Torres, A.2    Reyes, S.3
  • 27
    • 77957754399 scopus 로고    scopus 로고
    • Sociedad Espanola de Neumologa y Ciruga Toracica.Community acquired pneumonia New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)]
    • Menendez R, Torres A, Aspa J, et al. Sociedad Espanola de Neumologa y Ciruga Toracica.Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)]. Arch Bronconeumol 2010;46(10):543-58
    • (2010) Arch Bronconeumol , vol.46 , Issue.10 , pp. 543-558
    • Menendez, R.1    Torres, A.2    Aspa, J.3
  • 28
    • 84877920559 scopus 로고    scopus 로고
    • Determining the duration of therapy for patients with community-acquired pneumonia
    • Scalera NM, File TM Jr. Determining the duration of therapy for patients with community-acquired pneumonia. Curr Infect Dis Rep 2013;15(2):191-5
    • (2013) Curr Infect Dis Rep , vol.15 , Issue.2 , pp. 191-195
    • Scalera, N.M.1    File Jr., T.M.2
  • 29
    • 33745471090 scopus 로고    scopus 로고
    • Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial
    • Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006;174:84-93
    • (2006) Am J Respir Crit Care Med , vol.174 , pp. 84-93
    • Christ-Crain, M.1    Stolz, D.2    Bingisser, R.3
  • 30
    • 70149088214 scopus 로고    scopus 로고
    • Effect of procalcitonin based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The prohosp randomized controlled trial
    • Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin based guidelines vs. standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009;302:1059-66
    • (2009) JAMA , vol.302 , pp. 1059-1066
    • Schuetz, P.1    Christ-Crain, M.2    Thomann, R.3
  • 31
    • 36749072042 scopus 로고    scopus 로고
    • National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study
    • Critchley IA, Brown SD, Traczewski MM, et al. National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study. Antimicrob Agents Chemother 2007;51(12):4382-9
    • (2007) Antimicrob Agents Chemother , vol.51 , Issue.12 , pp. 4382-4389
    • Critchley, I.A.1    Brown, S.D.2    Traczewski, M.M.3
  • 32
    • 84892674223 scopus 로고    scopus 로고
    • Available from: http://www.earss.rivm.nl
  • 33
    • 30144441160 scopus 로고    scopus 로고
    • Penicillins for treatment of pneumococcal pneumonia: Does in vitro resistance really matter?
    • Peterson LR. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter? Clin Infect Dis 2006;42:224-33
    • (2006) Clin Infect Dis , vol.42 , pp. 224-233
    • Peterson, L.R.1
  • 34
    • 34547516914 scopus 로고    scopus 로고
    • Penicillin resistance not a factor in outcome from invasive streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started
    • Mufson MA, Chan G, Stanek RJ. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started. Am J Med Sci 2007;333:161-7
    • (2007) Am J Med Sci , vol.333 , pp. 161-167
    • Mufson, M.A.1    Chan, G.2    Stanek, R.J.3
  • 35
    • 36048991271 scopus 로고    scopus 로고
    • The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults
    • File TM Jr. The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults. Int J Antimicrob Agents 2007;30(Suppl 2):S131-4
    • (2007) Int J Antimicrob Agents , vol.30 , Issue.SUPPL. 2
    • File Jr., T.M.1
  • 36
    • 33746608911 scopus 로고    scopus 로고
    • Macrolide resistance in bacteremic pneumococcal disease: Implications for patient management
    • Daneman N, McGeer A, Green K, Low DE. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 2006;43(4):432-8
    • (2006) Clin Infect Dis , vol.43 , Issue.4 , pp. 432-438
    • Daneman, N.1    McGeer, A.2    Green, K.3    Low, D.E.4
  • 37
    • 78649873377 scopus 로고    scopus 로고
    • Integrated analysis of focus 1 and focus 2: Randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia
    • ceftaroline group were numerically higher than those for the ceftriaxone group, well tolerated and with a safety profile similar to that of ceftriaxone
    • File TM Jr, Low DE, Eckburg PB, et al. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis 2010;51(12):1395-405 ceftaroline group were numerically higher than those for the ceftriaxone group, well tolerated and with a safety profile similar to that of ceftriaxone.
    • (2010) Clin Infect Dis , vol.51 , Issue.12 , pp. 1395-1405
    • File Jr., T.M.1    Low, D.E.2    Eckburg, P.B.3
  • 39
    • 14644394235 scopus 로고    scopus 로고
    • Effectiveness of b-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: Meta-analysis
    • Mills GD, Oehley MR, Arrol B. Effectiveness of b-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005;330:456-60
    • (2005) BMJ , vol.330 , pp. 456-460
    • Mills, G.D.1    Oehley, M.R.2    Arrol, B.3
  • 40
    • 47049124628 scopus 로고    scopus 로고
    • Antibacterial class is not obviously important in outpatient pneumonia: A meta-analysis
    • Maimon N, Nopmaneejumruslers C, Marras TK. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Eur Respir J 2008;31(5):1068-76
    • (2008) Eur Respir J , vol.31 , Issue.5 , pp. 1068-1076
    • Maimon, N.1    Nopmaneejumruslers, C.2    Marras, T.K.3
  • 41
    • 14844300669 scopus 로고    scopus 로고
    • Immunomodulatory effects of macrolides: Implications for practicing clinicians
    • Siddiqui J. Immunomodulatory effects of macrolides: implications for practicing clinicians. Am J Med 2004;117:26S-9S
    • (2004) Am J Med , vol.117
    • Siddiqui, J.1
  • 43
    • 35448968988 scopus 로고    scopus 로고
    • Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro
    • Anderson R, Steel HC, Cockeran R, et al. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother 2007;60:1155-8
    • (2007) J Antimicrob Chemother , vol.60 , pp. 1155-1158
    • Anderson, R.1    Steel, H.C.2    Cockeran, R.3
  • 44
    • 58849166805 scopus 로고    scopus 로고
    • Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
    • Restrepo MI, Mortensen EM, Waterer GW, et al. Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. Eur Respir J 2009;33:153-9
    • (2009) Eur Respir J , vol.33 , pp. 153-159
    • Restrepo, M.I.1    Mortensen, E.M.2    Waterer, G.W.3
  • 45
    • 77951209165 scopus 로고    scopus 로고
    • Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia
    • Martin-Loeches I, Lisboa T, Rodriguez A, et al. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 2010;36:610-20
    • (2010) Intensive Care Med , vol.36 , pp. 610-620
    • Martin-Loeches, I.1    Lisboa, T.2    Rodriguez, A.3
  • 46
    • 33847173420 scopus 로고    scopus 로고
    • Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones
    • Metersky ML, Ma A, Houck PM, Bratzler DW. Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones. Chest 2007;131:466-73
    • (2007) Chest , vol.131 , pp. 466-473
    • Metersky, M.L.1    Ma, A.2    Houck, P.M.3    Bratzler, D.W.4
  • 47
    • 76549123321 scopus 로고    scopus 로고
    • Prospective, randomized study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalized patients with community-acquired pneumonia
    • Falguera M, Ruiz-Gonzalez A, Schoenenberger JA, et al. Prospective, randomized study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalized patients with community-acquired pneumonia. Thorax 2010;65:101-6
    • (2010) Thorax , vol.65 , pp. 101-106
    • Falguera, M.1    Ruiz-Gonzalez, A.2    Schoenenberger, J.A.3
  • 48
    • 79954578994 scopus 로고    scopus 로고
    • Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: Results from an international surveillance study
    • Jones RN, Farrell DJ, Mendes RE, Sader HS. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study. J Antimicrob Chemother 2011;66(Suppl 3):iii69-80
    • (2011) J Antimicrob Chemother , vol.66 , Issue.SUPPL. 3
    • Jones, R.N.1    Farrell, D.J.2    Mendes, R.E.3    Sader, H.S.4
  • 49
    • 84892677278 scopus 로고    scopus 로고
    • Available from: http://www.fda.gov/newsevents/newsroom/ pressannouncements/ucm231594.htm
  • 50
    • 50149119679 scopus 로고    scopus 로고
    • In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia
    • Bradford PA, Petersen PJ, Tuckman M, Jones CH. In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia. Clin Microbiol Infect 2008;14:882-6
    • (2008) Clin Microbiol Infect , vol.14 , pp. 882-886
    • Bradford, P.A.1    Petersen, P.J.2    Tuckman, M.3    Jones, C.H.4
  • 51
    • 57749206651 scopus 로고    scopus 로고
    • Tigecycline: In community-acquired pneumonia
    • McKeage K, Keating GM. Tigecycline: in community-acquired pneumonia. Drugs 2008;68:2633-44
    • (2008) Drugs , vol.68 , pp. 2633-2644
    • McKeage, K.1    Keating, G.M.2
  • 52
    • 57549104883 scopus 로고    scopus 로고
    • 308 Study Group Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: Results from a double-blind randomized phase 3 comparison study with levofloxacin
    • Bergallo C, Jasovich A, Teglia O, et al. 308 Study Group. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin. Diagn Microbiol Infect Dis 2009;63(1):52-61
    • (2009) Diagn Microbiol Infect Dis , vol.63 , Issue.1 , pp. 52-61
    • Bergallo, C.1    Jasovich, A.2    Teglia, O.3
  • 53
    • 70449359990 scopus 로고    scopus 로고
    • 313 Study Group Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
    • Tanaseanu C, Milutinovic S, Calistru PI, et al. 313 Study Group. Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia. BMC Pulm Med 2009;9:44
    • (2009) BMC Pulm Med , vol.9 , pp. 44
    • Tanaseanu, C.1    Milutinovic, S.2    Calistru, P.I.3
  • 54
    • 84892678500 scopus 로고    scopus 로고
    • Available from: http://www.fda.gov/Drugs/DrugSafety/ucm224370.ht
  • 55
    • 84863373784 scopus 로고    scopus 로고
    • Cethromycin versus clarithromycin for community-acquired pneumonia: Comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies
    • English ML, Fredericks CE, Milanesio NA, et al. Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies. Antimicrob Agents Chemother 2012;56(4):2037-47
    • (2012) Antimicrob Agents Chemother , vol.56 , Issue.4 , pp. 2037-2047
    • English, M.L.1    Fredericks, C.E.2    Milanesio, N.A.3
  • 56
    • 84875413952 scopus 로고    scopus 로고
    • A novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-kB inhibition
    • Kobayashi Y, Wada H, Rossios C, et al. A novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-kB inhibition. J Pharmacol Exp Ther 2013;345(1):76-84
    • (2013) J Pharmacol Exp Ther , vol.345 , Issue.1 , pp. 76-84
    • Kobayashi, Y.1    Wada, H.2    Rossios, C.3
  • 57
    • 84892680261 scopus 로고    scopus 로고
    • Available from: http://www.prnewswire. com/news-releases/cempra-inc- announcesinitiation-of-oral-solithromycin-globalphase-3-clinical-trial-in- patients-withcommunity-acquired-bacterialpneumonia-184082501.html
  • 58
    • 77953312824 scopus 로고    scopus 로고
    • Resistant pathogens in nonnosocomial pneumonia and respiratory failure: Is it time to refine the definition of health-care-associated pneumonia?
    • Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest 2010;137:1283-8
    • (2010) Chest , vol.137 , pp. 1283-1288
    • Schreiber, M.P.1    Chan, C.M.2    Shorr, A.F.3
  • 59
    • 34948846090 scopus 로고    scopus 로고
    • Health care-associated pneumonia and community-acquired pneumonia: A single-center experience
    • Micek ST, Kollef KE, Reichley RM, et al. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007;51:3568-73
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 3568-3573
    • Micek, S.T.1    Kollef, K.E.2    Reichley, R.M.3
  • 60
    • 44149101259 scopus 로고    scopus 로고
    • Pneumonia caused by methicillin-resistant Staphylococcus aureus
    • Review
    • Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008;46(Suppl 5):S378-85; Review
    • (2008) Clin Infect Dis , vol.46 , Issue.SUPPL. 5
    • Rubinstein, E.1    Kollef, M.H.2    Nathwani, D.3
  • 61
    • 79959711666 scopus 로고    scopus 로고
    • Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: A uk cohort study
    • e13
    • Chalmers JD, Taylor JK, Singanayagam A, et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 2011;53:107; e13
    • (2011) Clin Infect Dis , vol.53 , pp. 107
    • Chalmers, J.D.1    Taylor, J.K.2    Singanayagam, A.3
  • 62
    • 80053526515 scopus 로고    scopus 로고
    • Low incidence of multidrug resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization
    • Garcia-Vidal C, Viasus D, Roset A, et al. Low incidence of multidrug resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 2011;17:1659-65
    • (2011) Clin Microbiol Infect , vol.17 , pp. 1659-1665
    • Garcia-Vidal, C.1    Viasus, D.2    Roset, A.3
  • 63
    • 80053513739 scopus 로고    scopus 로고
    • Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
    • Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 2011;38:878-87
    • (2011) Eur Respir J , vol.38 , pp. 878-887
    • Attridge, R.T.1    Frei, C.R.2    Restrepo, M.I.3
  • 64
    • 79958810134 scopus 로고    scopus 로고
    • Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia
    • Grenier C, Pepin J, Nault V, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother 2011;66:1617-24
    • (2011) J Antimicrob Chemother , vol.66 , pp. 1617-1624
    • Grenier, C.1    Pepin, J.2    Nault, V.3
  • 65
    • 84864617002 scopus 로고    scopus 로고
    • Adding fuel to the flames? It is time to leave HCAP
    • Ewig S, Welte T. Adding fuel to the flames? It is time to leave HCAP. Respir Med 2012;106(9):1309-10
    • (2012) Respir Med , vol.106 , Issue.9 , pp. 1309-1310
    • Ewig, S.1    Welte, T.2
  • 66
    • 84555209205 scopus 로고    scopus 로고
    • Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department
    • Shorr AF, Zilberberg MD, Reichley R, et al. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 2012;54(2):193-8
    • (2012) Clin Infect Dis , vol.54 , Issue.2 , pp. 193-198
    • Shorr, A.F.1    Zilberberg, M.D.2    Reichley, R.3
  • 67
    • 84860236414 scopus 로고    scopus 로고
    • Pneumonia in the community caused by multidrug-resistant organisms: Keep working on probabilistic scores
    • Aliberti S, Zanaboni AM, Blasi F. Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores. Clin Infect Dis 2012;54(10):1519-20
    • (2012) Clin Infect Dis , vol.54 , Issue.10 , pp. 1519-1520
    • Aliberti, S.1    Zanaboni, A.M.2    Blasi, F.3
  • 68
    • 26844433194 scopus 로고    scopus 로고
    • Antiinflammatory action of glucocorticoids-new mechanisms for old drugs
    • Review
    • Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005;353(16):1711-23; Review
    • (2005) N Engl J Med , vol.353 , Issue.16 , pp. 1711-1723
    • Rhen, T.1    Cidlowski, J.A.2
  • 69
    • 0025153147 scopus 로고
    • A controlled trial of early adjunctive treatment with corticosteroids for pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
    • Bozzette SA, Sattler FR, Chiu J, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 1990;323(21):1451-7
    • (1990) California Collaborative Treatment Group. N Engl J Med , vol.323 , Issue.21 , pp. 1451-1457
    • Bozzette, S.A.1    Sattler, F.R.2    Chiu, J.3
  • 70
    • 19944430688 scopus 로고    scopus 로고
    • Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study
    • Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005;171:242-8
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 242-248
    • Confalonieri, M.1    Urbino, R.2    Potena, A.3
  • 71
    • 84868148522 scopus 로고    scopus 로고
    • Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings
    • Sabry NA, Omar EE-D. Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacol Pharm 2011;2:73-81
    • (2011) Pharmacol Pharm , vol.2 , pp. 73-81
    • Sabry, N.A.1    Omar, E.E.-D.2
  • 72
    • 79952561515 scopus 로고    scopus 로고
    • Effect of corticosteroids on the clinical course of community-acquired pneumonia: A randomized controlled trial
    • Fernandez-Serrano S, Dorca J, Garcia-Vidal C, et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care 2011;15:R96
    • (2011) Crit Care , vol.15 R , pp. 96
    • Fernandez-Serrano, S.1    Dorca, J.2    Garcia-Vidal, C.3
  • 73
    • 77952307234 scopus 로고    scopus 로고
    • Efficacy of corticosteroids in community-acquired pneumonia: A randomized double-blinded clinical trial
    • Snijders D, Daniels JM, de Graaff CS, et al. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med 2010;181:975-82
    • (2010) Am J Respir Crit Care Med , vol.181 , pp. 975-982
    • Snijders, D.1    Daniels, J.M.2    De Graaff, C.S.3
  • 74
    • 79958771376 scopus 로고    scopus 로고
    • Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: A randomized, double-blind, placebo-controlled trial
    • Meijvis SC, Hardeman H, Remmelts HH, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomized, double-blind, placebo-controlled trial. Lancet 2011;377:2023-30
    • (2011) Lancet , vol.377 , pp. 2023-2030
    • Meijvis, S.C.1    Hardeman, H.2    Remmelts, H.H.3
  • 75
    • 34548569037 scopus 로고    scopus 로고
    • Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization
    • Mikami K, Suzuki M, Kitagawa H, et al. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung 2007;185:249-55
    • (2007) Lung , vol.185 , pp. 249-255
    • Mikami, K.1    Suzuki, M.2    Kitagawa, H.3
  • 76
    • 84872896068 scopus 로고    scopus 로고
    • Systemic corticosteroids for community-acquired pneumonia: Reasons for use and lack of benefit on outcome
    • Polverino E, Cilloniz C, Dambrava P, et al. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome. Respirology 2013;18(2):263-71
    • (2013) Respirology , vol.18 , Issue.2 , pp. 263-271
    • Polverino, E.1    Cilloniz, C.2    Dambrava, P.3
  • 77
    • 84868087224 scopus 로고    scopus 로고
    • Corticosteroids in the treatment of community-acquired pneumonia in adults: A meta-analysis
    • Nie W, Zhang Y, Cheng J, Xiu Q. Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS One 2012;7(10):e47926
    • (2012) PLoS One , vol.7 , Issue.10
    • Nie, W.1    Zhang, Y.2    Cheng, J.3    Xiu, Q.4
  • 78
    • 84877920907 scopus 로고    scopus 로고
    • Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia?
    • Confalonieri M, Annane D, Antonaglia C, et al. Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? Curr Infect Dis Rep 2013;15(2):158-66
    • (2013) Curr Infect Dis Rep , vol.15 , Issue.2 , pp. 158-166
    • Confalonieri, M.1    Annane, D.2    Antonaglia, C.3
  • 79
    • 37549020378 scopus 로고    scopus 로고
    • Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008
    • Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327
    • (2008) Crit Care Med , vol.36 , pp. 296-327
    • Dellinger, R.P.1    Levy, M.M.2    Carlet, J.M.3
  • 80
    • 84892676597 scopus 로고    scopus 로고
    • Available from: http://clinicaltrials.gov/ct2/show/NCT00973154
  • 81
    • 37549040562 scopus 로고    scopus 로고
    • Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats
    • Choi G, Hofstra JJ, Roelofs JJ, et al. Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats. Crit Care Med 2008;36(1):204-10
    • (2008) Crit Care Med , vol.36 , Issue.1 , pp. 204-210
    • Choi, G.1    Hofstra, J.J.2    Roelofs, J.J.3
  • 82
    • 67650470156 scopus 로고    scopus 로고
    • Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study)
    • Jaimes F, De La Rosa G, Morales C, et al. Unfractioned heparin for treatment of sepsis: a randomized clinical trial (The HETRASE Study). Crit Care Med 2009;37(4):1185-96
    • (2009) Crit Care Med , vol.37 , Issue.4 , pp. 1185-1196
    • Jaimes, F.1    De La Rosa, G.2    Morales, C.3
  • 83
    • 46049090201 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition)
    • Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: american College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):381S-453S
    • (2008) Chest , vol.133 , Issue.6 SUPPL.
    • Geerts, W.H.1    Bergqvist, D.2    Pineo, G.F.3
  • 84
    • 0032698105 scopus 로고    scopus 로고
    • Acute respiratory failure in patients with severe community-acquired pneumonia A prospective randomized evaluation of noninvasive ventilation
    • Confalonieri M, Potena A, Carbone G, et al. Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med 1999;160(5 Pt 1):1585-91
    • (1999) Am J Respir Crit Care Med , vol.160 PART 1 , Issue.5 , pp. 1585-1591
    • Confalonieri, M.1    Potena, A.2    Carbone, G.3
  • 85
    • 0347362531 scopus 로고    scopus 로고
    • Noninvasive ventilation in severe hypoxemic respiratory failure: A randomized clinical trial
    • Ferrer M, Esquinas A, Leon M, et al. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003;168:1438-44
    • (2003) Am J Respir Crit Care Med , vol.168 , pp. 1438-1444
    • Ferrer, M.1    Esquinas, A.2    Leon, M.3
  • 86
    • 0034533147 scopus 로고    scopus 로고
    • Statins as a newly recognized type of immunomodulator
    • Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000;6(12):1399-402
    • (2000) Nat Med , vol.6 , Issue.12 , pp. 1399-1402
    • Kwak, B.1    Mulhaupt, F.2    Myit, S.3    Mach, F.4
  • 87
    • 20244378532 scopus 로고    scopus 로고
    • Simvastatin blunts endotoxin-induced tissue factor in vivo
    • Steiner S, Speid WS, Pleiner J, et al. Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation 2005;111(14):1841-6
    • (2005) Circulation , vol.111 , Issue.14 , pp. 1841-1846
    • Steiner, S.1    Speid, W.S.2    Pleiner, J.3
  • 88
    • 54349122201 scopus 로고    scopus 로고
    • Prior statin use is associated with improved outcomes in community-acquired pneumonia
    • e1
    • Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008;121(11):1002-7; e1
    • (2008) Am J Med , vol.121 , Issue.11 , pp. 1002-1007
    • Chalmers, J.D.1    Singanayagam, A.2    Murray, M.P.3    Hill, A.T.4
  • 89
    • 79961024148 scopus 로고    scopus 로고
    • Understanding the potential role of statins in pneumonia and sepsis
    • Yende S, Milbrandt EB, Kellum JA, et al. Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med 2011;39(8):1871-8
    • (2011) Crit Care Med , vol.39 , Issue.8 , pp. 1871-1878
    • Yende, S.1    Milbrandt, E.B.2    Kellum, J.A.3
  • 90
    • 79953905093 scopus 로고    scopus 로고
    • Effect of statin treatment on short term mortality after pneumonia episode: Cohort study
    • Douglas I, Evans S, Smeeth L. Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ 2011;342:d1642
    • (2011) BMJ , vol.342
    • Douglas, I.1    Evans, S.2    Smeeth, L.3
  • 91
    • 46349099104 scopus 로고    scopus 로고
    • Acute myocardial infarction in hospitalized patients with community-acquired pneumonia
    • Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. J Clin Infect Dis 2008;47(2):182-7
    • (2008) J Clin Infect Dis , vol.47 , Issue.2 , pp. 182-187
    • Ramirez, J.1    Aliberti, S.2    Mirsaeidi, M.3
  • 92
    • 84872253001 scopus 로고    scopus 로고
    • The role of statins in prevention and treatment of community acquired pneumonia: A systematic review and meta-analysis
    • Khan AR, Riaz M, Bin Abdulhak AA, et al. The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PLoS One 2013;8(1):e52929
    • (2013) PLoS One , vol.8 , Issue.1
    • Khan, A.R.1    Riaz, M.2    Bin Abdulhak, A.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.